Heritage Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Heritage Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-150	Closed	-$1K	–	560
2021 Q4	$1K	Hold	150	–	–	﹤0.01%	532
2021 Q3	$1.46K	Hold	150	–	–	﹤0.01%	507
2021 Q2	$1.49K	Buy	+150	New	+$1.59K	﹤0.01%	517
2019 Q3	–	Sell	-10	Closed	-$92	–	467
2019 Q2	$92	Sell	10 -130	-93%	-$1.57K	﹤0.01%	445
2019 Q1	$2.19K	Hold	140	–	–	﹤0.01%	409
2018 Q4	$2K	Hold	140	–	–	﹤0.01%	365
2018 Q3	$3K	Buy	+140	New	+$3.25K	﹤0.01%	347

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Heritage Wealth Advisors's TEVA Position: Q1 2022 in Review

Heritage Wealth Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2022, closing a stake of 150 shares — an estimated $1K sold.

Heritage Wealth Advisors first reported a position in TEVA in Q3 2018 and held it in 7 quarters. The position peaked at $3K in Q3 2018. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

Heritage Wealth Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2022 after selling out during the quarter.
Heritage Wealth Advisors sold 150 Teva Pharmaceutical Industries Limited shares in Q1 2022, an estimated $1K.
Heritage Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q3 2018 and held it in 7 quarters.
Heritage Wealth Advisors's Teva Pharmaceutical Industries Limited position peaked at $3K in Q3 2018.
438 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2022.

Based on Heritage Wealth Advisors's 13F filing for Q1 2022, filed 11 May 2022.